| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad6144dce423313e8a56bbb571386e0e |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 |
| filingDate |
2021-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_007b7ac91e6cab8f305ba6ed2cfea289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60cfcfeb3898e151400f157581e1d01 |
| publicationDate |
2022-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2022069437-A |
| titleOfInvention |
Pharmaceutical product and its manufacturing method |
| abstract |
PROBLEM TO BE SOLVED: To provide granules containing a non-volatile solvent useful for manufacturing a pharmaceutical product such as a surfactant and vitamins and having excellent fluidity capable of withstanding actual production. A pharmaceutical preparation in the form of granules comprising nuclear particles and a coating layer covering the nuclear particles. The nuclear particles comprises a drug, a nuclear particle component and a non-volatile solvent. The BET specific surface area of the nuclear particle component is 0.45 m 2 / g or more, and the BET specific surface area is 0.45 m 2 / g or more. The pharmaceutical product having a content of the non-volatile solvent per unit mass of the pharmaceutical product of 10 mg or more. [Selection diagram] None |
| priorityDate |
2020-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |